News related to Misoprostol and/or conditions it is approved for
Can EP4 Agonist Alleviate Gastric Lesions?
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2009.11.19]
Over 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in the world to treat pain, arthritis, fever and other diseases. Nearly 30% of the users suffer from gastric lesions and bleeding. To mitigate NSAIDs' adverse effects on the stomach, misoprostol, a non-selective prostaglandin E1 (PGE1) analogue, has been prescribed as the first choice for prevention of NSAID-induced injuries, but often induces severe adverse effects.
|
